{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:04:06Z","timestamp":1794377046434,"version":"4.9.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T00:00:00Z","timestamp":1618617600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T00:00:00Z","timestamp":1618617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81620108020"],"award-info":[{"award-number":["81620108020"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572447"],"award-info":[{"award-number":["81572447"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatitis B virus (HBV) infection remains a major health issue worldwide and the leading cause of cirrhosis and hepatocellular carcinoma (HCC). It has been reported previously that HBV invasion can extensively alter transcriptome, the proteome of exosomes and host cell lipid rafts. The impact of HBV on host proteins through regulating their global post-translational modifications (PTMs), however, is not well studied. Viruses have been reported to exploit cellular processes by enhancing or inhibiting the ubiquitination of specific substrates. Nevertheless, host cell physiology in terms of global proteome and ubiquitylome has not been addressed yet. Here by using HBV-integrated HepG2.2.15 model cell line we first report that HBV significantly modify the host global ubiquitylome. As currently the most widely used HBV cell culture model, HepG2.2.15 can be cultivated for multiple generations for protein labeling, and can replicate HBV, express HBV proteins and secrete complete HBV Dane particles, which makes it a suitable cell line for ubiquitylome analysis to study HBV replication, hepatocyte immune response and HBV-related HCC progression. Our previous experimental results showed that the total ubiquitination level of HepG2.2.15 cell line was significantly higher than that of the corresponding parental HepG2 cell line. By performing a Ubiscan quantification analysis based on stable isotope labeling of amino acids in cell culture (SILAC) of HepG2.2.15 and HepG2 cell lines, we identified a total of 7188 proteins and the protein levels of nearly 19% of them were changed over 2-folds. We further identified 3798 ubiquitinated Lys sites in 1476 host proteins with altered ubiquitination in response to HBV. Our results also showed that the global proteome and ubiquitylome were negatively correlated, indicating that ubiquitination might be involved in the degradation of host proteins upon HBV integration. We first demonstrated the ubiquitination change of VAMP3, VAMP8, DNAJB6, RAB8A, LYN, VDAC2, OTULIN, SLC1A4, SLC1A5, HGS and TOLLIP. In addition, we described 5 novel host factors SLC1A4, SLC1A5, EIF4A1, TOLLIP and BRCC36 that efficiently reduced the amounts of secreted HBsAg and HBeAg. Overall, the HBV-mediated host proteome and ubiquitylome change we reported will provide a valuable resource for further investigation of HBV pathogenesis and host-virus interaction networks.<\/jats:p>","DOI":"10.1186\/s13578-021-00588-3","type":"journal-article","created":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T09:03:03Z","timestamp":1618650183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Global analysis of HBV-mediated host proteome and ubiquitylome change in HepG2.2.15 human hepatoblastoma cell line"],"prefix":"10.1186","volume":"11","author":[{"given":"Sen","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousaf","family":"Tanzeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naz","family":"Wajeeha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuopeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8816-3952","authenticated-orcid":false,"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,17]]},"reference":[{"issue":"18","key":"588_CR1","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.4254\/wjh.v7.i18.2127","volume":"7","author":"LC Meireles","year":"2015","unstructured":"Meireles LC, Marinho RT, Damme PV. Liliane C Meireles, Rui Tato Marinho, Pierre Van Damme. World J Hepatol. 2015;7(18):2127\u201332. https:\/\/doi.org\/10.4254\/wjh.v7.i18.2127.","journal-title":"World J Hepatol"},{"issue":"7","key":"588_CR2","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.1365-2036.2009.03932.x","volume":"29","author":"G Nguyen","year":"2009","unstructured":"Nguyen G, Garcia RT, Nguyen N, Trinh H, Keeffe EB, Nguyen MH. Clinical course of hepatitis B virus infection during pregnancy. Aliment Pharmacol Ther. 2009;29(7):755\u201364. https:\/\/doi.org\/10.1111\/j.1365-2036.2009.03932.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"588_CR3","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1128\/jvi.02440-14","volume":"89","author":"S Rawat","year":"2015","unstructured":"Rawat S, Bouchard MJ. The hepatitis B virus (HBV) HBx protein activates AKT to simultaneously regulate HBV replication and hepatocyte survival. J Virol. 2015;89(2):999\u20131012. https:\/\/doi.org\/10.1128\/jvi.02440-14.","journal-title":"J Virol"},{"issue":"3","key":"588_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.14218\/JCTH.2017.00024","volume":"5","author":"G Ray","year":"2017","unstructured":"Ray G. Current scenario of hepatitis B and its treatment in India. J Clin Transl Hepatol. 2017;5(3):277\u201396. https:\/\/doi.org\/10.14218\/JCTH.2017.00024.","journal-title":"J Clin Transl Hepatol"},{"issue":"2","key":"588_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.canlet.2010.11.014","volume":"305","author":"MJ Bouchard","year":"2011","unstructured":"Bouchard MJ, Navas-Martin S. Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett. 2011;305(2):123\u201343. https:\/\/doi.org\/10.1016\/j.canlet.2010.11.014.","journal-title":"Cancer Lett"},{"issue":"2","key":"588_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","volume":"48","author":"F Giovanna","year":"2008","unstructured":"Giovanna F, Bortolotti F, Francesco D. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48(2):335\u201352. https:\/\/doi.org\/10.1016\/j.jhep.2007.11.011.","journal-title":"J Hepatol"},{"issue":"5","key":"588_CR7","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.cell.2010.11.012","volume":"143","author":"MJ Clague","year":"2010","unstructured":"Clague MJ, Urb\u00e9 S. Ubiquitin: same molecule, different degradation pathways. Cell. 2010;143(5):682\u20135. https:\/\/doi.org\/10.1016\/j.cell.2010.11.012.","journal-title":"Cell"},{"issue":"5","key":"588_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrm3099","volume":"12","author":"C Grabbe","year":"2011","unstructured":"Grabbe C, Husnjak K, Dikic I. The spatial and temporal organization of ubiquitin networks. Nat Rev Mol Cell Biol. 2011;12(5):295\u2013307. https:\/\/doi.org\/10.1038\/nrm3099.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"588_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","volume":"26","author":"KN Swatek","year":"2016","unstructured":"Swatek KN, Komander D. Ubiquitin modifications. Cell Res. 2016;26(4):399\u2013422. https:\/\/doi.org\/10.1038\/cr.2016.39.","journal-title":"Cell Res"},{"issue":"7237","key":"588_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature07963","volume":"458","author":"S Bergink","year":"2009","unstructured":"Bergink S, Jentsch S. Principles of ubiquitin and SUMO modifications in DNA repair. Nature. 2009;458(7237):461\u20137. https:\/\/doi.org\/10.1038\/nature07963.","journal-title":"Nature"},{"issue":"1","key":"588_CR11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1104\/pp.16.00795","volume":"173","author":"J Guo","year":"2017","unstructured":"Guo J, Liu J, Wei Q, Wang R, Yang W, Ma Y, Chen G, Yu Y. Proteomes and ubiquitylomes analysis reveals the involvement of ubiquitination in protein degradation in petunias. Plant Physiol. 2017;173(1):668\u201387. https:\/\/doi.org\/10.1104\/pp.16.00795.","journal-title":"Plant Physiol"},{"issue":"November","key":"588_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jprot.2017.10.014","volume":"172","author":"L van der Wal","year":"2018","unstructured":"van der Wal L, Bezstarosti K, Sap KA, Dekkers DHW, Rijkers E, Mientjes E, Elgersma Y, Demmers JAA. Improvement of ubiquitylation site detection by Orbitrap mass spectrometry. J Proteom. 2018;172(November):49\u201356. https:\/\/doi.org\/10.1016\/j.jprot.2017.10.014.","journal-title":"J Proteom"},{"issue":"2","key":"588_CR13","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/cells3020386","volume":"3","author":"A Calistri","year":"2014","unstructured":"Calistri A, Munegato D, Carli I, Parolin C, Pal\u00f9 G. The ubiquitin-conjugating system: multiple roles in viral replication and infection. Cells. 2014;3(2):386\u2013417. https:\/\/doi.org\/10.3390\/cells3020386.","journal-title":"Cells"},{"issue":"10","key":"588_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v8100293","volume":"8","author":"A Rudnicka","year":"2016","unstructured":"Rudnicka A, Yamauchi Y. Ubiquitin in influenza virus entry and innate immunity. Viruses. 2016;8(10):1\u201315. https:\/\/doi.org\/10.3390\/v8100293.","journal-title":"Viruses"},{"issue":"1","key":"588_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.virusres.2010.09.023","volume":"155","author":"TL Gearhart","year":"2011","unstructured":"Gearhart TL, Bouchard MJ. The hepatitis B virus HBx protein modulates cell cycle regulatory proteins in cultured primary human hepatocytes. Virus Res. 2011;155(1):363\u20137. https:\/\/doi.org\/10.1016\/j.virusres.2010.09.023.","journal-title":"Virus Res"},{"issue":"2","key":"588_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1005438","volume":"12","author":"J Lamontagne","year":"2016","unstructured":"Lamontagne J, Mell JC, Bouchard MJ. Transcriptome-wide analysis of hepatitis B virus-mediated changes to normal hepatocyte gene expression. PLoS Pathog. 2016;12(2):1\u201335. https:\/\/doi.org\/10.1371\/journal.ppat.1005438.","journal-title":"PLoS Pathog"},{"issue":"2","key":"588_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5009\/gnl.2007.1.2.101","volume":"1","author":"NH Park","year":"2007","unstructured":"Park NH, Song IH, Chung Y-H. Molecular pathogenesis of hepatitis-B-virus-associated hepatocellular carcinoma. Gut Liver. 2007;1(2):101\u201317. https:\/\/doi.org\/10.5009\/gnl.2007.1.2.101.","journal-title":"Gut Liver"},{"key":"588_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.virol.2014.05.027","volume":"462\u2013463","author":"CL Song","year":"2014","unstructured":"Song CL, Ren JH, Ran LK, Li YG, Li XS, Chen X, Li WY, Huang AL, Chen J. Cyclin D2 plays a regulatory role in HBV replication. Virology. 2014;462\u2013463:149\u201357. https:\/\/doi.org\/10.1016\/j.virol.2014.05.027.","journal-title":"Virology"},{"key":"588_CR19","doi-asserted-by":"publisher","first-page":"41089","DOI":"10.1038\/srep41089","volume":"7","author":"Q Xie","year":"2017","unstructured":"Xie Q, Fan F, Wei W, Liu Y, Xu Z, Zhai L, Qi Y, Ye B, Zhang Y, Basu S, Zhao Z, Wu J, Xu P. Multi-omics analyses reveal metabolic alterations regulated by hepatitis B virus core protein in hepatocellular carcinoma cells. Sci Rep. 2017;7:41089. https:\/\/doi.org\/10.1038\/srep41089.","journal-title":"Sci Rep"},{"issue":"4","key":"588_CR20","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1074\/mcp.M116.063503","volume":"16","author":"X Jia","year":"2017","unstructured":"Jia X, Chen J, Megger DA, Zhang X, Kozlowski M, Zhang L, Fang Z, Li J, Chu Q, Wu M, Li Y, Sitek B, Yuan Z. Label-free proteomic analysis of exosomes derived from inducible hepatitis B virus-replicating HepAD38 cell line. Mol Cell Proteom. 2017;16(4):S144\u201360. https:\/\/doi.org\/10.1074\/mcp.M116.063503.","journal-title":"Mol Cell Proteom"},{"issue":"12","key":"588_CR21","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.1021\/pr5008703","volume":"13","author":"X Zhao","year":"2014","unstructured":"Zhao X, Wu Y, Duan J, Ma Y, Shen Z, Wei L, Cui X, Zhang J, Xie Y, Liu J. Quantitative proteomic analysis of exosome protein content changes induced by hepatitis B virus in Huh-7 cells using SILAC labeling and LC-MS\/MS. J Proteome Res. 2014;13(12):5391\u2013402. https:\/\/doi.org\/10.1021\/pr5008703.","journal-title":"J Proteome Res"},{"issue":"1","key":"588_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-019-1183-z","volume":"16","author":"F Kong","year":"2019","unstructured":"Kong F, You H, Kong D, Zheng K, Tang R. The interaction of hepatitis B virus with the ubiquitin proteasome system in viral replication and associated pathogenesis. Virol J. 2019;16(1):1\u201310. https:\/\/doi.org\/10.1186\/s12985-019-1183-z.","journal-title":"Virol J"},{"issue":"6","key":"588_CR23","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.21037\/tcr.2018.11.30","volume":"7","author":"M Jiang","year":"2018","unstructured":"Jiang M, Hua Z, Dong Y, Liu Z, Thiele CJ, Li Z. Quantitative ubiquitylome analysis and crosstalk with proteome\/acetylome analysis identified novel pathways and targets of perifosine treatment in neuroblastoma. Transl Cancer Res. 2018;7(6):1548\u201360. https:\/\/doi.org\/10.21037\/tcr.2018.11.30.","journal-title":"Transl Cancer Res"},{"issue":"SUPPL. 2","key":"588_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/nar\/gkm259","volume":"35","author":"P Horton","year":"2007","unstructured":"Horton P, Park KJ, Obayashi T, Fujita N, Harada H, Adams-Collier CJ, Nakai K. WoLF PSORT: protein localization predictor. Nucleic Acids Res. 2007;35(SUPPL. 2):585\u20137. https:\/\/doi.org\/10.1093\/nar\/gkm259.","journal-title":"Nucleic Acids Res"},{"issue":"SUPPL. 66","key":"588_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/0471140864.ps1405s66","volume":"1","author":"JD Laney","year":"2011","unstructured":"Laney JD, Hochstrasser M. Analysis of protein ubiquitination. Curr Protocols Protein Sci. 2011;1(SUPPL. 66):1\u201313. https:\/\/doi.org\/10.1002\/0471140864.ps1405s66.","journal-title":"Curr Protocols Protein Sci"},{"issue":"6","key":"588_CR26","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1089\/ars.2011.4137","volume":"16","author":"ON Spindel","year":"2012","unstructured":"Spindel ON, World C, Berk BC. Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms. Antioxid Redox Signal. 2012;16(6):587\u201396. https:\/\/doi.org\/10.1089\/ars.2011.4137.","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"588_CR27","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.18632\/oncotarget.13904","volume":"8","author":"AV Ivanov","year":"2017","unstructured":"Ivanov AV, Valuev-Elliston VT, Tyurina DA, Ivanova ON, Kochetkov SN, Bartosch B, Isaguliants MG. Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis. Oncotarget. 2017;8(3):3895\u2013932. https:\/\/doi.org\/10.18632\/oncotarget.13904.","journal-title":"Oncotarget"},{"issue":"19","key":"588_CR28","doi-asserted-by":"publisher","first-page":"e00722","DOI":"10.1128\/JVI.00722-18","volume":"92","author":"Y Xia","year":"2018","unstructured":"Xia Y, Cheng X, Li Y, Valdez K, Chen W, Jake T, Liang J-H, James Ou (2018) Hepatitis B virus deregulates the cell cycle to promote viral replication and a premalignant phenotype. J Virol 92(19):e00722\u201318","journal-title":"J Virol"},{"issue":"3","key":"588_CR29","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jprot.2011.09.011","volume":"75","author":"N Xie","year":"2012","unstructured":"Xie N, Huang K, Zhang T, Lei Y, Liu R, Wang K, Zhou S, Li J, Wu J, Wu H, Deng C, Zhao X, Nice EC, Huang C. Comprehensive proteomic analysis of host cell lipid rafts modified by HBV infection. J Proteom. 2012;75(3):725\u201339. https:\/\/doi.org\/10.1016\/j.jprot.2011.09.011.","journal-title":"J Proteom"},{"issue":"11","key":"588_CR30","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nmeth1109-786","volume":"6","author":"N Colaert","year":"2009","unstructured":"Colaert N, Helsens K, Martens L, Vandekerckhove J, Gevaert K. Improved visualization of protein consensus sequences by iceLogo. Nat Methods. 2009;6(11):786\u20137. https:\/\/doi.org\/10.1038\/nmeth1109-786.","journal-title":"Nat Methods"},{"key":"588_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.biopha.2018.02.038","volume":"100","author":"IS Mohammad","year":"2018","unstructured":"Mohammad IS, He W, Yin L. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR. Biomed Pharmacother. 2018;100:335\u201348. https:\/\/doi.org\/10.1016\/j.biopha.2018.02.038.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"588_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1005123","volume":"11","author":"SF Chou","year":"2015","unstructured":"Chou SF, Tsai ML, Huang JY, Chang YS, Shih C. The dual role of an ESCRT-0 component HGS in HBV transcription and naked capsid secretion. PLoS Pathog. 2015;11(10):1\u201328. https:\/\/doi.org\/10.1371\/journal.ppat.1005123.","journal-title":"PLoS Pathog"},{"issue":"5","key":"588_CR33","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1096\/fj.201801995RR","volume":"33","author":"Y Lin","year":"2019","unstructured":"Lin Y, Wu C, Wang X, Liu S, Kemper T, Li F, Squire A, Zhu Y, Zhang J, Chen X, Lu M. Synaptosomal-associated protein 29 is required for the autophagic degradation of hepatitis B virus. FASEB J. 2019;33(5):6023\u201334. https:\/\/doi.org\/10.1096\/fj.201801995RR.","journal-title":"FASEB J"},{"key":"588_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2018.00166","author":"F Elgner","year":"2018","unstructured":"Elgner F, Hildt E, Bender D. Relevance of rab proteins for the life cycle of hepatitis C virus. Front Cell Dev Biol. 2018. https:\/\/doi.org\/10.3389\/fcell.2018.00166.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"588_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.virol.2008.09.021","volume":"382","author":"RK Rowe","year":"2008","unstructured":"Rowe RK, Suszko JW, Pekosz A. Roles for the recycling endosome, Rab8, and Rab11 in hantavirus release from epithelial cells. Virology. 2008;382(2):239\u201349. https:\/\/doi.org\/10.1016\/j.virol.2008.09.021.","journal-title":"Virology"},{"issue":"1","key":"588_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.biocel.2012.09.021","volume":"45","author":"T El-Bacha","year":"2013","unstructured":"El-Bacha T, Da Poian AT. Virus-induced changes in mitochondrial bioenergetics as potential targets for therapy. Int J Biochem Cell Biol. 2013;45(1):41\u20136. https:\/\/doi.org\/10.1016\/j.biocel.2012.09.021.","journal-title":"Int J Biochem Cell Biol"},{"key":"588_CR37","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1038\/srep08421","volume":"5","author":"H Li","year":"2015","unstructured":"Li H, Zhu W, Zhang L, Lei H, Wu X, Guo L, Chen X, Wang Y, Tang H. The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment. Sci Rep. 2015;5:8421. https:\/\/doi.org\/10.1038\/srep08421.","journal-title":"Sci Rep"},{"issue":"1","key":"588_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.virol.2012.03.027","volume":"429","author":"A Kawabata","year":"2012","unstructured":"Kawabata A, Jasirwan C, Yamanishi K, Mori Y. Human herpesvirus 6 glycoprotein M is essential for virus growth and requires glycoprotein N for its maturation. Virology. 2012;429(1):21\u20138. https:\/\/doi.org\/10.1016\/j.virol.2012.03.027.","journal-title":"Virology"},{"issue":"15","key":"588_CR39","doi-asserted-by":"publisher","first-page":"8565","DOI":"10.1128\/jvi.00388-14","volume":"88","author":"R Meier","year":"2014","unstructured":"Meier R, Franceschini A, Horvath P, Tetard M, Mancini R, von Mering C, Helenius A, Lozach P-Y. Genome-wide small interfering RNA screens reveal VAMP3 as a novel host factor required for Uukuniemi virus late penetration. J Virol. 2014;88(15):8565\u201378. https:\/\/doi.org\/10.1128\/jvi.00388-14.","journal-title":"J Virol"},{"issue":"1","key":"588_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13046-018-0681-y","volume":"37","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Song G, Yao L, Liu Y, Liu M, Li S, Tang H. miR-3928v is induced by HBx via NF-\u03baB\/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3. J Exp Clin Cancer Res. 2018;37(1):14. https:\/\/doi.org\/10.1186\/s13046-018-0681-y.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"588_CR41","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1099\/vir.0.81684-0","volume":"87","author":"SY Sohn","year":"2006","unstructured":"Sohn SY, Kim SB, Kim J, Ahn BY. Negative regulation of hepatitis B virus replication by cellular Hsp40\/DnaJ proteins through destabilization of viral core and X proteins. J Gen Virol. 2006;87(7):1883\u201391. https:\/\/doi.org\/10.1099\/vir.0.81684-0.","journal-title":"J Gen Virol"},{"issue":"December","key":"588_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep40246","volume":"7","author":"ZJ Su","year":"2017","unstructured":"Su ZJ, Cao JS, Wu YF, Chen WN, Lin X, Wu YL, Lin X. Deubiquitylation of hepatitis B virus X protein (HBx) by ubiquitin-specific peptidase 15 (USP15) increases HBx stability and its transactivation activity. Sci Rep. 2017;7(December):1\u201311. https:\/\/doi.org\/10.1038\/srep40246.","journal-title":"Sci Rep"},{"issue":"5","key":"588_CR43","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.celrep.2019.09.069","volume":"29","author":"D Li","year":"2019","unstructured":"Li D, Wu R, Guo W, Xie L, Qiao Z, Chen S, Zhu J, Huang C, Huang J, Chen B, Qin Y, Xu F, Ma F. STING-mediated IFI16 degradation negatively controls type I interferon production. Cell Rep. 2019;29(5):1249-1260.e4. https:\/\/doi.org\/10.1016\/j.celrep.2019.09.069.","journal-title":"Cell Rep"},{"issue":"2","key":"588_CR44","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/hep.23011","volume":"50","author":"B Gao","year":"2009","unstructured":"Gao B, Duan Z, Xu W, Xiong S. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain. Hepatology. 2009;50(2):424\u201333. https:\/\/doi.org\/10.1002\/hep.23011.","journal-title":"Hepatology"},{"key":"588_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070001","author":"S Zhang","year":"2013","unstructured":"Zhang S, Guo JT, Wu JZ, Yang G. Identification and characterization of multiple TRIM proteins that inhibit hepatitis B virus transcription. PLoS ONE. 2013. https:\/\/doi.org\/10.1371\/journal.pone.0070001.","journal-title":"PLoS ONE"},{"issue":"February","key":"588_CR46","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.1002\/jcph.768","volume":"56","author":"A Atilano-Roque","year":"2016","unstructured":"Atilano-Roque A, Roda G, Fogueri U, Kiser JJ, Joy MS. Effect of disease pathologies on transporter expression and function. J Clin Pharmacol. 2016;56(February):S205\u201321. https:\/\/doi.org\/10.1002\/jcph.768.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"588_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-46952-9","volume":"9","author":"A Moskovskich","year":"2019","unstructured":"Moskovskich A, Goldmann U, Kartnig F, Lindinger S, Konecka J, Fiume G, Girardi E, Superti-Furga G. The transporters SLC35A1 and SLC30A1 play opposite roles in cell survival upon VSV virus infection. Sci Rep. 2019;9(1):1\u201311. https:\/\/doi.org\/10.1038\/s41598-019-46952-9.","journal-title":"Sci Rep"},{"key":"588_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5214187","author":"L He","year":"2018","unstructured":"He L, Wang B, Li Y, Zhu L, Li P, Zou F, Bin L. The solute carrier transporter SLC15A3 participates in antiviral innate immune responses against herpes simplex virus-1. J Immunol Res. 2018. https:\/\/doi.org\/10.1155\/2018\/5214187.","journal-title":"J Immunol Res"},{"issue":"3","key":"588_CR49","doi-asserted-by":"publisher","first-page":"92140","DOI":"10.1371\/journal.pone.0092140","volume":"9","author":"S Bocchetta","year":"2014","unstructured":"Bocchetta S, Maillard P, Yamamoto M, Gondeau C, Douam F, Lebreton S, Lagaye S, Pol S, Helle F, Plengpanich W, Gue\u0155in M, Bourgine M, Michel ML, Lavillette D, Roingeard P, Le Goff W, Budkowska A. Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection. PLoS ONE. 2014;9(3):92140. https:\/\/doi.org\/10.1371\/journal.pone.0092140.","journal-title":"PLoS ONE"},{"issue":"1","key":"588_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-33861-6","volume":"8","author":"NNT Nguyen","year":"2018","unstructured":"Nguyen NNT, Lim YS, Nguyen LP, Tran SC, Luong TTD, Nguyen TTT, Pham HT, Mai HN, Choi JW, Han SS, Hwang SB. Hepatitis C virus modulates solute carrier family 3 member 2 for viral propagation. Sci Rep. 2018;8(1):1\u201314. https:\/\/doi.org\/10.1038\/s41598-018-33861-6.","journal-title":"Sci Rep"},{"key":"588_CR51","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s10555-020-09879-6","volume":"39","author":"R Sutherland","year":"2020","unstructured":"Sutherland R, Meeson A, Lowes S (2020) Solute transporters and malignancy: establishing the role of uptake transporters in breast cancer and breast cancer metastasis. Cancer Metastasis Rev 39(3):919\u2013932. https:\/\/doi.org\/10.1007\/s10555-020-09879-6","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"588_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-56059-w","volume":"9","author":"L Cervenkova","year":"2019","unstructured":"Cervenkova L, Vycital O, Bruha J, Rosendorf J, Palek R, Liska V, Daum O, Mohelnikova-Duchonova B, Soucek P (2019) Protein expression of ABCC2 and SLC22A3 associates with prognosis of pancreatic adenocarcinoma. Sci Rep 9(1):1\u20139. https:\/\/doi.org\/10.1038\/s41598-019-56059-w","journal-title":"Sci Rep"},{"issue":"8","key":"588_CR53","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00439-016-1683-5","volume":"135","author":"T Geuens","year":"2016","unstructured":"Geuens T, Bouhy D, Timmerman V. The hnRNP family: insights into their role in health and disease. Hum Genet. 2016;135(8):851\u201367. https:\/\/doi.org\/10.1007\/s00439-016-1683-5.","journal-title":"Hum Genet"},{"issue":"7","key":"588_CR54","doi-asserted-by":"publisher","first-page":"0673","DOI":"10.1371\/journal.pmed.0020163","volume":"2","author":"LFP Ng","year":"2005","unstructured":"Ng LFP, Chan M, Chan SH, Cheng PCP, Leung EHC, Chen WN, Ren EC. Host heterogeneous ribonucleoprotein K (hnRNP K) as a potential target to suppress hepatitis B virus replication. PLoS Med. 2005;2(7):0673\u201383. https:\/\/doi.org\/10.1371\/journal.pmed.0020163.","journal-title":"PLoS Med"},{"key":"588_CR55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1756-8722-5-37","volume":"5","author":"Y Guo","year":"2012","unstructured":"Guo Y, Zhao J, Bi J, Wu Q, Wang X, Lai Q. Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early hepatocellular carcinoma in patients with cirrhosis. J Hematol Oncol. 2012;5:37. https:\/\/doi.org\/10.1186\/1756-8722-5-37.","journal-title":"J Hematol Oncol"},{"issue":"13","key":"588_CR56","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.1128\/jvi.00225-14","volume":"88","author":"Y Li","year":"2014","unstructured":"Li Y, Masaki T, Shimakami T, Lemon SM. hnRNP L and NF90 Interact with hepatitis C virus 5\u2032-terminal untranslated RNA and promote efficient replication. J Virol. 2014;88(13):7199\u2013209. https:\/\/doi.org\/10.1128\/jvi.00225-14.","journal-title":"J Virol"},{"issue":"21","key":"588_CR57","doi-asserted-by":"publisher","first-page":"15046","DOI":"10.1074\/jbc.M113.466136","volume":"288","author":"R Gao","year":"2013","unstructured":"Gao R, Yu Y, Inoue A, Widodo N, Kaul SC, Wadhwa R. Heterogeneous nuclear ribonucleoprotein K (hnRNP-K) promotes tumor metastasis by induction of genes involved in extracellular matrix, cell movement, and angiogenesis. J Biol Chem. 2013;288(21):15046\u201356. https:\/\/doi.org\/10.1074\/jbc.M113.466136.","journal-title":"J Biol Chem"},{"key":"588_CR58","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijbiomac.2019.02.012","volume":"129","author":"RS Ke","year":"2019","unstructured":"Ke RS, Zhang K, Lv LZ, Dong YP, Pan F, Yang F, Cai QC, Jiang Y. Prognostic value and oncogene function of heterogeneous nuclear ribonucleoprotein A1 overexpression in HBV-related hepatocellular carcinoma. Int J Biol Macromol. 2019;129:140\u201351.","journal-title":"Int J Biol Macromol"},{"key":"588_CR59","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1038\/s41375-019-0517-6","volume":"33","author":"O Landgren","year":"2019","unstructured":"Landgren O, Sonneveld P, Jakubowiak A, Mohty M, Iskander KS, Mezzi K, Siegel DS. Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma. Leukemia. 2019;33:2127\u201343.","journal-title":"Leukemia"},{"key":"588_CR60","doi-asserted-by":"publisher","first-page":"7085","DOI":"10.1158\/1078-0432.CCR-09-0822","volume":"15","author":"OA O'Connor","year":"2009","unstructured":"O\u2019Connor OA, Stewart AK, Vallone M, Molineaux CJ, Kunkel LA, Gerecitano JF, Orlowski RZ. A phase 1 dose escalation study of the safety and pharmacokinetics of the novel proteasome inhibitor carfilzomib (PR-171) in patients with hematologic malignancies. Clin Cancer Res. 2009;15:7085\u201391.","journal-title":"Clin Cancer Res"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-021-00588-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-021-00588-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-021-00588-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T09:17:09Z","timestamp":1618651029000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-021-00588-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,17]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["588"],"URL":"https:\/\/doi.org\/10.1186\/s13578-021-00588-3","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,17]]},"assertion":[{"value":"18 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publish this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}